Amazon cover image
      Image from Amazon.com
      Image from Google Jackets

      Kinesins and Cancer [electronic resource] / edited by Frank Kozielski, FSB.

      Contributor(s): Material type: TextTextPublisher: Dordrecht : Springer Netherlands : Imprint: Springer, 2015Description: X, 271 p. 50 illus., 32 illus. in color. online resourceContent type:
      • text
      Media type:
      • computer
      Carrier type:
      • online resource
      ISBN:
      • 9789401797320
      Subject(s): Additional physical formats: Printed edition:: No titleDDC classification:
      • 614.5999 23
      LOC classification:
      • RC261-271
      Online resources:
      Contents:
      Preface -- The kinesin superfamily -- The discovery and development of Eg5 inhibitors for the clinic -- Mechanism of action of Eg5 inhibitors -- Clinical trials of mitotic kinesin inhibitors -- Kif15; a useful target for anti-cancer therapy?.- Down-regulating CENP-E activity: for better or for worse -- The human kinesin-14 motor KifC1/HSET is an attractive anti-cancer drug target.-Kinesin-13 Microtubule Depolymerizing Proteins as targets for cancer therapy -- Chromokinesins in genome maintenance and cancer -- Kif14: a clinically relevant kinesin and potential target for cancer therapy -- Kinesin-8 members and their potential as biomarker or therapeutic target -- The kinesin-6 members MKLP1, MKLP2 and MPP -- Non-motor spindle proteins as cancer chemotherapy targets -- Inhibitors of mitotic kinesins for cancer treatment: consequences for neurons -- Index.
      In: Springer eBooksSummary: This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development. Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future. The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail.
      Tags from this library: No tags from this library for this title. Log in to add tags.
      Star ratings
          Average rating: 0.0 (0 votes)
      Holdings
      Item type Current library Call number URL Status Notes Date due Barcode
      e-Books e-Books SARVAJNA LIBRARY, UHS, BAGALKOT 614.5999 (Browse shelf(Opens below)) Link to resource Available Click on the URL to access eBook EB542

      Preface -- The kinesin superfamily -- The discovery and development of Eg5 inhibitors for the clinic -- Mechanism of action of Eg5 inhibitors -- Clinical trials of mitotic kinesin inhibitors -- Kif15; a useful target for anti-cancer therapy?.- Down-regulating CENP-E activity: for better or for worse -- The human kinesin-14 motor KifC1/HSET is an attractive anti-cancer drug target.-Kinesin-13 Microtubule Depolymerizing Proteins as targets for cancer therapy -- Chromokinesins in genome maintenance and cancer -- Kif14: a clinically relevant kinesin and potential target for cancer therapy -- Kinesin-8 members and their potential as biomarker or therapeutic target -- The kinesin-6 members MKLP1, MKLP2 and MPP -- Non-motor spindle proteins as cancer chemotherapy targets -- Inhibitors of mitotic kinesins for cancer treatment: consequences for neurons -- Index.

      This interdisciplinary volume collates research work on kinesins and cancer. Authors attempt to validate members of the kinesin superfamily as potential targets for drug development in cancer chemotherapy. The work begins by highlighting the importance of kinesins, summarising current knowledge and how they are shown to be crucial for mitosis. Chapters go on to explore how this family of proteins are emerging as a novel target for chemotherapeutic intervention and drug development. Readers will learn how kinesins travel along microtubules to fulfill their many roles in intracellular transport or cell division. Several compounds that inhibit two mitotic kinesins (called Eg5 and CENP-E) have entered Phase I and II clinical trials and are explored in these chapters. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the repertoire of kinesin-based drug targets may expand in the future. The book is suitable as a reference standard for the field of kinesins and cancer. It will interest those in academia and pharmaceutical companies, and anyone with an interest in the medical relevance of these proteins, which cutting edge methodologies are now enabling us to understand in astonishing detail.

      There are no comments on this title.

      to post a comment.
      External Imp. Links

      UHSB || ICAR || IDEAL: A Union Catalog of NARS Libraries || KrushiKosh (Digital Library) || Kanaja (ಕಣಜ – ಕನ್ನಡ ಜ್ಞಾನಕೋಶ) || Karnataka Gazetteer || ASRB || Employment News || ಉದ್ಯೋಗ ಮಾಹಿತಿ || || Karnataka Digital Public Library ||


      For more Information please contact Librarian @ Sarvajna Library, UHS, Bagalkot OR Dr. Gireesh A Ganjihal Assistant Librarian
      "Healthy Soils for a Healthy Life"

      page counter